Anti-counterfeiting playbook for small- and mid-sized pharma companies
Learn how to implement risk-based anti-counterfeiting strategies that are critical to the success of a product launch
Add bookmark
While larger pharma companies generally have anti-counterfeiting programs in place for risk management measures, small- and mid-sized pharma companies often overlook the critical need to implement product security measures early due to having limited management bandwidth.
For quick and easy strategy advice to overcome counterfeit risk when developing pharmaceutical products, download Authentix’s short guidebook.
Share best practice, ideas, and solutions to our global community of more than 125,000 senior pharmaceutical and biotech professionals. View our latest Media Kit to learn more about our audience and review our content calendar. Download NowInterested in presenting your own Case Study?
Come away with lessons in how to:
- Implement an advanced anti-counterfeiting program (ACP) for newly launched products.
- Reduce significant risk in the pharma supply chain by following an ACP roadmap.
- Five key steps for implementing an effective ACP program.
